The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
15d-PGJ2: The anti-inflammatory prostaglandin?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Rho GTPases and the Actin Cytoskeleton
Hall, A. (1998) · Science · doi:10.1126/science.279.5350.509 · Cited by 6,140
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
Johnson, G. L., & Lapadat, R. (2002) · Science · doi:10.1126/science.1072682 · Cited by 4,295
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
The RXR heterodimers and orphan receptors
Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,158
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
A decade of molecular biology of retinoic acid receptors
Chambon, P. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.9.8801176 · Cited by 2,889
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734
Cyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506
Prostanoid Receptors: Structures, Properties, and Functions
Narumiya, S., Sugimoto, Y., & Ushikubi, F. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1193 · Cited by 2,412
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
Nagy, L., Tontonoz, P., Alvarez, J. G. A., Chen, H., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81574-3 · Cited by 1,860
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797
9-cis retinoic acid is a high affinity ligand for the retinoid X receptor
Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., Stein, R. B., Eichele, G., Evans, R. M., & Thaller, C. (1992) · Cell · doi:10.1016/0092-8674(92)90479-v · Cited by 1,780
Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A., & Evans, R. M. (1992) · Nature · doi:10.1038/358771a0 · Cited by 1,741
Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb
Jiang, J., & Struhl, G. (1998) · Nature · doi:10.1038/35154 · Cited by 1,735
Coleman, R. A., Smith, W. L., & Narumiya, S. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06784-5 · Cited by 1,735
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
McGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., & Santoro, M. G. (2000) · Nature · doi:10.1038/47520 · Cited by 1,310
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
lpr And gld: Single Gene Models Of Systemic Autoimmunity And Lymphoproliferative Disease
Cohen, P. (1991) · Annual Review of Immunology · doi:10.1146/annurev.immunol.9.1.243 · Cited by 1,196
Characterization of three RXR genes that mediate the action of 9-cis retinoic acid.
Mangelsdorf, D. J., Borgmeyer, U., Heyman, R. A., Zhou, J. Y., Ong, E. S., Oro, A. E., Kakizuka, A., & Evans, R. M. (1992) · Genes & Development · doi:10.1101/gad.6.3.329 · Cited by 1,190
Prostaglandins as modulators of immunity
Harris, S. G., Padilla, J., Koumas, L., Ray, D., & Phipps, R. P. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02154-8 · Cited by 1,180
PPARγ: a Nuclear Regulator of Metabolism, Differentiation, and Cell Growth
Rosen, E. D., & Spiegelman, B. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100034200 · Cited by 1,175
Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M., Torra, I. P., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J.-C., et al. (1998) · Nature · doi:10.1038/31701 · Cited by 1,134
Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M., & Kliewer, S. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3406 · Cited by 1,110
Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K., Nakamura, M., Takano, S., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.255 · Cited by 1,099
Chawla, A., Barak, Y., Nagy, L., Liao, D., Tontonoz, P., & Evans, R. M. (2001) · Nature Medicine · doi:10.1038/83336 · Cited by 1,069
15-Deoxy-Δ 12,14 -prostaglandin J 2 inhibits multiple steps in the NF-κB signaling pathway
Straus, D. S., Pascual, G., Li, M., Welch, J. S., Ricote, M., Hsiang, C.-H., Sengchanthalangsy, L. L., Ghosh, G., & Glass, C. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4844 · Cited by 1,004
Differentiation and reversal of malignant changes in colon cancer through PPARγ
Sarraf, P., Mueller, E., Jones, D., King, F. J., DeAngelo, D. J., Partridge, J. B., Holden, S. A., Chen, L. B., Singer, S., Fletcher, C., et al. (1998) · Nature Medicine · doi:10.1038/2030 · Cited by 988
Chinetti, G., Fruchart, J.-C., & Staels, B. (2000) · Inflammation Research · doi:10.1007/s000110050622 · Cited by 954
Chinetti, G., Griglio, S., Antonucci, M., Torra, I. P., Delerive, P., Majd, Z., Fruchart, J.-C., Chapman, J., Najib, J., & Staels, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25573 · Cited by 903
Chawla, A., Schwarz, E. J., Dimaculangan, D. D., & Lazar, M. A. (1994) · Endocrinology · doi:10.1210/en.135.2.798 · Cited by 873
The eicosanoids and their biochemical mechanisms of action
Smith, W. L. (1989) · Biochemical Journal · doi:10.1042/bj2590315 · Cited by 871
Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase
Huang, J. T., Welch, J. S., Ricote, M., Binder, C. J., Willson, T. M., Kelly, C., Witztum, J. L., Funk, C. D., Conrad, D., & Glass, C. K. (1999) · Nature · doi:10.1038/22572 · Cited by 855
Terminal Differentiation of Human Breast Cancer through PPARγ
Mueller, E., Sarraf, P., Tontonoz, P., Evans, R. M., Martin, K. J., Zhang, M., Fletcher, C., Singer, S., & Spiegelman, B. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80047-7 · Cited by 851
A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
Su, C. G., Wen, X., Bailey, S. T., Jiang, W., Rangwala, S. M., Keilbaugh, S. A., Flanigan, A., Murthy, S., Lazar, M. A., & Wu, G. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7145 · Cited by 767
Kudo, I., & Murakami, M. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00020-5 · Cited by 757
Ricote, M., Huang, J., Fajas, L., Li, A., Welch, J., Najib, J., Witztum, J. L., Auwerx, J., Palinski, W., & Glass, C. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7614 · Cited by 721
Lemberger, T., Desvergne, B., & Wahli, W. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.335 · Cited by 712
Cyclooxygenase-2: A Therapeutic Target
Turini, M. E., & DuBois, R. N. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103952 · Cited by 683
Zhu, Y., Qi, C., Korenberg, J. R., Chen, X. N., Noya, D., Rao, M. S., & Reddy, J. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7921 · Cited by 653
Lefebvre, A.-M., Chen, I., Desreumaux, P., Najib, J., Fruchart, J.-C., Geboes, K., Briggs, M., Heyman, R., & Auwerx, J. (1998) · Nature Medicine · doi:10.1038/2036 · Cited by 611
Cytokines, Prostaglandins and Parturition—A Review
Keelan, J. A., Blumenstein, M., Helliwell, R. J. A., Sato, T. A., Marvin, K. W., & Mitchell, M. D. (2003) · Placenta · doi:10.1053/plac.2002.0948 · Cited by 606
Marx, N., Sukhova, G. K., Collins, T., Libby, P., & Plutzky, J. (1999) · Circulation · doi:10.1161/01.cir.99.24.3125 · Cited by 599
Activators of the nuclear receptor PPARγ enhance colon polyp formation
Saez, E., Tontonoz, P., Nelson, M. C., Alvarez, J. G. A., U, T. M., Baird, S. M., Thomazy, V. A., & Evans, R. M. (1998) · Nature Medicine · doi:10.1038/2042 · Cited by 587
PPARγ2 Regulates Adipose Expression of the Phosphoenolpyruvate Carboxykinase Gene
Tontonoz, P., Hu, E., Devine, J., Beale, E. G., & Spiegelman, B. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.351 · Cited by 559
Macrophages in Human Atheroma Contain PPARγ
Marx, N., Sukhova, G., Murphy, C., Libby, P., & Plutzky, J. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65540-x · Cited by 529
Adams, M., Montague, C. T., Prins, J. B., Holder, J. C., Smith, S. A., Sanders, L., Digby, J. E., Sewter, C. P., Lazar, M. A., Chatterjee, V. K., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119870 · Cited by 517
Orphan Nuclear Receptors: Shifting Endocrinology into Reverse
Kliewer, S. A., Lehmann, J. M., & Willson, T. M. (1999) · Science · doi:10.1126/science.284.5415.757 · Cited by 499
Combs, C. K., Johnson, D. E., Karlo, J. C., Cannady, S. B., & Landreth, G. E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00558.2000 · Cited by 483
Schmidt, A. (1992) · Molecular Endocrinology · doi:10.1210/me.6.10.1634 · Cited by 477
Chinetti, G., Gbaguidi, F. G., Griglio, S., Mallat, Z., Antonucci, M., Poulain, P., Chapman, J., Fruchart, J.-C., Tedgui, A., Najib-Fruchart, J., et al. (2000) · Circulation · doi:10.1161/01.cir.101.20.2411 · Cited by 428
Mueller, E., Smith, M., Sarraf, P., Kroll, T., Aiyer, A., Kaufman, D. S., Oh, W., Demetri, G., Figg, W. D., Zhou, X.-P., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180329197 · Cited by 426
Bishop-Bailey, D., & Hla, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17042 · Cited by 424
Greene, M. E., Blumberg, B., McBride, O. W., Yi, H., Kronquist, K. E., Kwan, K. W., Hsieh, L., Greene, G. L., & Nimer, S. D. (1995) · Europe PMC (PubMed Central) · Cited by 399
15-Deoxy-Δ12,14-prostaglandin J2
Shibata, T., Kondo, M., Osawa, T., Shibata, N., Kobayashi, M., & Uchida, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110314200 · Cited by 392
Altiok, S., Xu, M., & Spiegelman, B. M. (1997) · Genes & Development · doi:10.1101/gad.11.15.1987 · Cited by 378
15-deoxy-Δ12,14-PGJ2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats
Kawahito, Y., Kondo, M., Tsubouchi, Y., Hashiramoto, A., Bishop-Bailey, D., Inoue, K.-I., Kohno, M., Yamada, R., Hla, T., & Sano, H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9652 · Cited by 377
Zhu, Y., Alvares, K., Huang, Q., Rao, M. S., & Reddy, J. K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74184-2 · Cited by 374
Jackson, S. M., Parhami, F., Xi, X.-P., Berliner, J. A., Hsueh, W. A., Law, R. E., & Demer, L. L. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.9.2094 · Cited by 373
Mangelsdorf, D. J., Kliewer, S. A., Kakizuka, A., Umesono, K., & Evans, R. M. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-571148-7.50008-7 · Cited by 356
Zhu, Y., Qi, C., Jain, S., Rao, M. S., & Reddy, J. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25500 · Cited by 346
Biosynthesis of 15-deoxy-Δ12,14-PGJ2 and the ligation of PPARγ
Bell-Parikh, L. C., Ide, T., Lawson, J. A., McNamara, P., Reilly, M., & FitzGerald, G. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18012 · Cited by 341
The role of PPARs in inflammation and immunity
Clark, R. B. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.3.388 · Cited by 337
Spencer, A. G., Woods, J. W., Arakawa, T., Singer, I. I., & Smith, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9886 · Cited by 334
Urade, Y., & Hayaishi, O. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00161-8 · Cited by 332
Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro.
Fitzpatrick, F. A., & Wynalda, M. A. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44287-6 · Cited by 328
Marx, N., Mach, F., Sauty, A., Leung, J. H., Sarafi, M. N., Ransohoff, R. M., Libby, P., Plutzky, J., & Luster, A. D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6503 · Cited by 296
Heneka, M. T., Klockgether, T., & Feinstein, D. L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-18-06862.2000 · Cited by 269
Castrillo, A., Díaz-Guerra, M. J. M., Hortelano, S., Martín-Sanz, P., & Boscá, L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1692-1698.2000 · Cited by 264
The role of PPARs in atherosclerosis
Duval, C., Chinetti, G., Trottein, F., Fruchart, J.-C., & Staels, B. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02385-7 · Cited by 246
Colville-Nash, P. R., Qureshi, S. S., Willis, D., & Willoughby, D. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.978 · Cited by 241
Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice
Eguchi, N., Minami, T., Shirafuji, N., Kanaoka, Y., Tanaka, T., Nagata, A., Yoshida, N., Urade, Y., Ito, S., & Hayaishi, O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.726 · Cited by 237
Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis
Fajas, L., Debril, M., & Auwerx, J. (2001) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0270001 · Cited by 231
Shu, H., Wong, B., Zhou, G., Li, Y., Berger, J., Woods, J. W., Wright, S. D., & Cai, T.-Q. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1968 · Cited by 229
Burstein, H. J., Demetri, G. D., Mueller, E., Sarraf, P., Spiegelman, B. M., & Winer, E. P. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1024038127156 · Cited by 228
Differential expression of the ras gene family in mice.
Leon, J., Guerrero, I., & Pellicer, A. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.4.1535 · Cited by 222
Endogenous PPARγ mediates anti-inflammatory activity in murine ischemia-reperfusion injury
Nakajima, A., Wada, K., Miki, H., Kubota, N., Nakajima, N., Terauchi, Y., Ohnishi, S., Saubermann, L. J., Kadowaki, T., Blumberg, R. S., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.21191 · Cited by 216
Peroxisome Proliferator-Activated Receptors, Coactivators, and Downstream Targets
Qi, C., Zhu, Y., & Reddy, J. K. (2000) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:32:1-3:187 · Cited by 216
Fahmi, H., Di Battista, J. A., Pelletier, J.-P., Mineau, F., Ranger, P., & Martel-Pelletier, J. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200103)44:3<595::aid-anr108>3.0.co;2-8 · Cited by 203
Prostaglandin synthases: recent developments and a novel hypothesis
Helliwell, R. J. A., Adams, L. F., & Mitchell, M. D. (2004) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.04.002 · Cited by 203
Fenofibrate and Rosiglitazone Lower Serum Triglycerides with Opposing Effects on Body Weight
Chaput, E., Saladin, R., Silvestre, M., & Edgar, A. D. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2647 · Cited by 199
Coupling between Cyclooxygenase, Terminal Prostanoid Synthase, and Phospholipase A2
Ueno, N., Murakami, M., Tanioka, T., Fujimori, K., Tanabe, T., Urade, Y., & Kudo, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100429200 · Cited by 195
Biological activities and mechanisms of action of PGJ2 and related compounds: an update
Fukushima, M. (1992) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(92)90178-l · Cited by 186
Tsuboi, K., Sugimoto, Y., & Ichikawa, A. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00054-0 · Cited by 180
Landreth, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00296-2 · Cited by 169
Cyclo‐oxygenase isoenzymes: physiological and pharmacological role
Kam, P. C. A., & See, A. U. (2000) · Anaesthesia · doi:10.1046/j.1365-2044.2000.01271.x · Cited by 158
Henry, R. R. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70267-x · Cited by 152
Occurrence of 9-deoxy-delta 9,delta 12-13,14-dihydroprostaglandin D2 in human urine.
Hirata, Y., Hayashi, H., Ito, S., Kikawa, Y., Ishibashi, M., Sudo, M., Miyazaki, H., Fukushima, M., Narumiya, S., & Hayaishi, O. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37435-0 · Cited by 145
Prevention of Allergic Inflammation by a Novel Prostaglandin Receptor Antagonist, S-5751
Arimura, A., Yasui, K., Kishino, J., Asanuma, F., Hasegawa, H., Kakudo, S., Ohtani, M., & Arita, H. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29398-8 · Cited by 142
Distribution of Cox-1 and Cox-2 in Normal and Inflamed Tissues
Seibert, K., Zhang, Y., Leahy, K., et al. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5325-0_24 · Cited by 141
Bordji, K., Grillasca, J., Gouze, J.-N., Magdalou, J., Schohn, H., Keller, J., Bianchi, A., Dauça, M., Netter, P., & Terlain, B. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12243 · Cited by 134
PPAR and Immune System-What Do We Know?
Zhang, X., & Young, H. A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00057-7 · Cited by 123
The cyclopentenone 15-deoxy-Δ 12,14 -prostaglandin J 2 binds to and activates H-Ras
Oliva, J. L., Pérez‐Sala, D., Castrillo, A., Martínez, N., Cañada, F. J., Boscá, L., & Rojas, J. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0735842100 · Cited by 123
Narumiya, S., & Fukushima, M. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23605-9 · Cited by 123
Nosjean, O., & Boutin, J. A. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00281-9 · Cited by 121
Effects of prostaglandin D2 on helper T cell functions
Tanaka, K., Hirai, H., Takano, S., Nakamura, M., & Nagata, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.151 · Cited by 119
Nuclear receptor signaling in macrophages
Valledor, A. F., & Ricote, M. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.10.016 · Cited by 117
Pentreath, V. W., Rees, K., Owolabi, O. A., Philip, K. A., & Doua, F. (1990) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(90)90085-s · Cited by 116
15-Deoxy-Δ12,1412,14-prostaglandins D2 and J2 Are Potent Activators of Human Eosinophils
Monneret, G., Li, H., Vasilescu, J., Rokach, J., & Powell, W. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3563 · Cited by 113
Prostaglandin D2 in Sleep-Wake Regulation: Recent Progress and Perspectives
Hayaishi, O., & Urade, Y. (2002) · The Neuroscientist · doi:10.1177/107385840200800105 · Cited by 109
Kanaoka, Y., Fujimori, K., Kikuno, R. F., Sakaguchi, Y., Urade, Y., & Hayaishi, O. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01362.x · Cited by 106
Serhan, C. N., & Chiang, N. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(03)00117-0 · Cited by 103
15-deoxy-Δ12,14-PGJ2: endogenous PPARγ ligand or minor eicosanoid degradation product?
Powell, W. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19796 · Cited by 100
Differential Regulation of Chemokine Gene Expression by 15-Deoxy-Δ12,1412,14 Prostaglandin J2
Zhang, X., Wang, J. M., Gong, W., Mukaida, N., & Young, H. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7104 · Cited by 90
Hayaishi, O. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00766.2001 · Cited by 90
Shan, Z., Masuko, K., Dai, S., Nakamura, H., Kato, T., & Nishioka, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402424200 · Cited by 85
Vaidya, S., Somers, E. P., Wright, S. D., Detmers, P. A., & Bansal, V. S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6187 · Cited by 83
Vaidya, S., Somers, E. P., Wright, S. D., Detmers, P. A., & Bansal, V. S. (1999) · PubMed · Cited by 81
Wright, D. H., Metters, K. M., Abramovitz, M., & Ford‐Hutchinson, A. W. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701708 · Cited by 76
MICHIMATA, T., Tsuda, H., Sakai, M., Fujimura, M., Nagata, K., Nakamura, M., & Saito, S. (2002) · Molecular Human Reproduction · doi:10.1093/molehr/8.2.181 · Cited by 75
Reilly, C. M., Oates, J. C., Cook, J. A., Morrow, J. D., Halushka, P. V., & Gilkeson, G. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1498 · Cited by 74
Kunz, T., Marklund, N., Hillered, L., & Oliw, E. H. (2002) · Journal of Neurotrauma · doi:10.1089/089771502760341965 · Cited by 73
Monneret, G., Cossette, C., Gravel, S., Rokach, J., & Powell, W. S. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042937 · Cited by 70
Wada, K., Nakajima, A., & Blumberg, R. S. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02076-7 · Cited by 68
Qi, C., Surapureddi, S., Zhu, Y.-J., Yu, S., Kashireddy, P. V., Rao, M. S., & Reddy, J. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300175200 · Cited by 65
Activation of nuclear receptors by prostaglandins
Ide, T., Egan, K. M., Bell, L. C., & FitzGerald, G. A. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00418-3 · Cited by 63
A Cyclopentenone Prostaglandin Activates Mesangial MAP Kinase Independently of PPARγ
Wilmer, W. A., Dixon, C. L., Lu, L., Hilbelink, T., & Rovin, B. H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4301 · Cited by 60
Fahmi, H., Pelletier, J.-P., Mineau, F., & Pelletier, J. (2002) · Osteoarthritis and Cartilage · doi:10.1053/joca.2002.0835 · Cited by 60
Inhibition of nociceptin‐induced allodynia in conscious mice by prostaglandin D2
Minami, T., Okuda‐Ashitaka, E., Nishizawa, M., Mori, H., & Ito, S. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701421 · Cited by 59
15-Deoxy-Δ12,14-prostaglandin J2 Inhibits IL-10 and IL-12 Production by Macrophages
Azuma, Y., Shinohara, M., Wang, P., & Ohura, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4783 · Cited by 55
Peroxisome Proliferator-activated Receptor γ-mediated Differentiation
Gupta, R. A., Sarraf, P., Mueller, E., Brockman, J. A., Prusakiewicz, J. J., Eng, C., Willson, T. M., & DuBois, R. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300637200 · Cited by 55
Dual Function of Troglitazone in ICAM-1 Gene Expression in Human Vascular Endothelium
Chen, N.-G., & Han, X. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4628 · Cited by 45
Sinha, D., Addya, S., Murer, E., & Boden, G. H. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90180-4 · Cited by 44
Cyclopentenone prostaglandin receptors
Negishi, M., & Katoh, H. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00059-x · Cited by 42
Cloning of novel members of the steroid hormone receptor superfamily
Issemann, I., & Green, S. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90191-7 · Cited by 31
Peroxisome proliferator-activated receptor γ and atherosclerosis
Marx, N. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0056-8 · Cited by 23
Antineoplastic and anti–inflammatory effects of PPAR ligands in colitis
Su, C. G., & Lewis, J. D. (2001) · Gastroenterology · doi:10.1016/s0016-5085(01)70084-4 · Cited by 14
Structural Diversity of Peroxisome Proliferators and Their Effects on Mammalian Liver Cells in Vivo
de la Iglesia, F. A., McGuire, E. J., Haskins, J. R., & Lalwani, N. D. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18625.x · Cited by 9
Cited by
Prostaglandin E2 synthesis and secretion: The role of PGE2 synthases
Park, J. Y., Pillinger, M. H., & Abramson, S. B. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.01.016 · Cited by 793
Self-citationSubra, C., Grand, D., Laulagnier, K., Stella, A., Lambeau, G., Paillasse, M., De Medina, P., Monsarrat, B., Perret, B., Silvente-Poirot, S., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003657 · Cited by 633
Macrophages and Tissue Injury: Agents of Defense or Destruction?
Laskin, D. L., Sunil, V. R., Gardner, C. R., & Laskin, J. D. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105812 · Cited by 604
Cell signalling by reactive lipid species: new concepts and molecular mechanisms
Higdon, A., Diers, A. R., Oh, J. Y., Landar, A., & Darley-Usmar, V. M. (2012) · Biochemical Journal · doi:10.1042/bj20111752 · Cited by 317
The Anti-Inflammatory Effects of Prostaglandins
Scher, J. U., & Pillinger, M. H. (2009) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31819aaa76 · Cited by 259
Self-citation
Metadata
- Authors
- Scher, J. U., & Pillinger, M. H.
- Venue
- Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2005-02
- Volume
- 114
- Issue
- 2
- Pages
- 100-109
- ISSN
- 1521-6616 (ISSN-L)
- OpenAlex
- W1994659489
- Cited by
- 348
- References
- 138
- FWCI
- 7.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.